Automated machine learning (AutoML)-based, data-driven, biomarker discovery pipeline approachReadmore
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
17 Jun
2024
Automated machine learning (AutoML)-based, data-driven, biomarker discovery pipeline approachReadmore
14 Aug
2024
Chris Berka on Advancing Early Detection of Neurodegenerative Diseases with EEG Biomarkers
The CEO and cofounder of Advanced Brain Monitoring discussed a study presented at AAIC 2024, which investigated the use of EEG biomarkers to distinguish between Alzheimer's disease and frontotemporal dementia.Readmore
22 Apr
2024
NeuroSense Therapeutics Ltd. collaborate with Genetika+ for Alzheimer's Disease (AD) drug developmentReadmore
25 April
2024
Study Discovers Potential Biomarkers of Environmental Exposures in Parkinson’s Disease
A team of Northwestern Medicine investigators has discovered novel DNA methylation patterns in the blood of patients with Parkinson’s disease, according to findings published in Annals of Neurology. Readmore
03 July
2024
Scientists May Have Found How to Diagnose Elusive Neuro Disorder
The discovery of a unique pattern of proteins in the spinal fluid of patients may help with earlier diagnosis and new treatments for progressive supranuclear palsy.Readmore
5 Sep
2024
UCF Researchers Develop Rapid Test to Detect Dopamine
The sensor could serve as a low-cost and efficient tool for early detection of neurological disorders and conditions, including Parkinson’s disease, Alzheimer’s disease and depression.Readmore
30 Oct
2024
Silent Intruder: How the Cold Sore Virus Maps its Way Through the Brain
CU Anschutz researchers provide a better understanding of the long-term consequences of HSV-1 infectionReadmore
22 Aug
2024
Momentous occasion': UCL experts greet first drug approved for early Alzheimer’s disease in the UK
The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer’s disease in the UK, following decades of work supported by UCL research.Readmore
14 MAY
2024
Olive oil may reduce risk of death from dementia
People who incorporate olive oil into their everyday diet may decrease their risk of dementia-related death, according to a new study by Harvard T.H. Chan School of Public Health.Readmore
08 JAN
2024
Life span increases in mice when specific brain cells are activated
Brain cells communicate with fat tissue to produce cellular fuel, counteract effects of agingReadmore
30 OCT
2023
Penn Medicine Receives $5 Million Grant to Study Next Generation of Dementia Treatments
Penn physicians and scientists will lead studies on underlying mechanisms of Alzheimer’s disease and related dementias with a grant from the Delaware Community FoundationReadmore
19 OCT
2023
Surgery-free brain stimulation could provide new treatment for dementia
A new form of deep brain stimulation offers hope for an alternative treatment option for dementia, without the need for surgery.Readmore